| 000 | 01778 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250517095727.0 | ||
| 264 | 0 | _c20170202 | |
| 008 | 201702s 0 0 eng d | ||
| 022 | _a1432-0584 | ||
| 024 | 7 |
_a10.1007/s00277-016-2700-4 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aJain, Tania | |
| 245 | 0 | 0 |
_aCytomegalovirus infection in autologous stem cell transplant recipients in the era of rituximab. _h[electronic resource] |
| 260 |
_bAnnals of hematology _cAug 2016 |
||
| 300 |
_a1323-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 |
_aCytomegalovirus _xgenetics |
| 650 | 0 | 4 |
_aCytomegalovirus Infections _xdiagnosis |
| 650 | 0 | 4 |
_aDNA, Viral _xgenetics |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNeoplasms _xclassification |
| 650 | 0 | 4 | _aPolymerase Chain Reaction |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 |
_aRisk Assessment _xmethods |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 |
_aRituximab _xadministration & dosage |
| 650 | 0 | 4 |
_aStem Cell Transplantation _xmethods |
| 650 | 0 | 4 | _aTransplantation, Autologous |
| 650 | 0 | 4 |
_aViremia _xdiagnosis |
| 650 | 0 | 4 | _aVirus Activation |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aJohn, Jisha | |
| 700 | 1 | _aKotecha, Aditya | |
| 700 | 1 | _aDeol, Abhinav | |
| 700 | 1 | _aSaliminia, Tanaz | |
| 700 | 1 | _aRevankar, Sanjay | |
| 700 | 1 | _aChandrasekar, Pranatharthi | |
| 773 | 0 |
_tAnnals of hematology _gvol. 95 _gno. 8 _gp. 1323-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00277-016-2700-4 _zAvailable from publisher's website |
| 999 |
_c26059448 _d26059448 |
||